The risk associated with being male or having an unmethylated MGMT promoter did not reach statistical significance (p = 0.446, HR = 1.33 (0.65 to 2.88) and p = 0.202, HR = 1.74 (0.77 to 4.26), respectively).
← all excerpts
Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma.
1
0.4460
0.4460